- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01256216
Signature Versus Computer Assisted Surgery Study
A Comparison of Signature Custom Cutting Guides and Computer Assisted Surgery Techniques With the Vanguard Knee System
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Vanguard® Knee System using Signature™ Custom Guides and Computer Assisted Surgery.
FDA has cleared the Vanguard Knee via premarket notification 510(k) K023546, K033489, and K050222. FDA has cleared the software for the Signature™ Custom Guides via premarket notification 510(k) K073449. The data gathered will be collated and used to provide feedback to design engineers, support marketing efforts, answer potential questions from reimbursement agencies, and will serve as a part of Biomet's Post Market Surveillance System.
Function will be assessed through the Knee Society Score. Survivorship will be documented by asking the surgeon to document revisions and complications.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Dudley, United Kingdom
- Russells Hall Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Inclusion criteria are identical to the indications for use stated in the FDA cleared labeling for the device (510(k) K023546, K033489, and K050222).
These indications are stated below:
- Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved.
- Correction of varus, valgus, or posttraumatic deformity.
- Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous joint replacement procedure.
- The Regenerex™ femoral augments are indicated for use with the Vanguard® Total Knee System.
- The Regenerex™ tibial augments are indicated for use with standard and offset Biomet® Tibial Trays.
Patient selection factors to be considered include:
- Need to obtain pain relief and improve function
- Ability and willingness of the patient to follow instructions, including control of weight and activity level
- A good nutritional state of the patient, and
- The patient must have reached full skeletal maturity
- Femoral components and tibial tray components with porous coatings are indicated for cemented and uncemented biological fixation application. Non-coated (Interlok™) devices and all polyethylene patellar components are indicated for cemented application only.
Exclusion Criteria: Exclusion criteria are identical to the contraindications stated in the FDA cleared labeling for the device 510(k) K023546, K033489, and K050222. These contraindications are stated below:
- Absolute contraindications include: infection, sepsis, and osteomyelitis
- Relative contraindications include:
- Uncooperative patient or patient with neurologic disorders who is incapable of following directions
- Osteoporosis
- Metabolic disorders which may impair bone formation,
- Osteomalacia
- Distant foci of infections which may spread to the implant site
- Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
- Vascular insufficiency, muscular atrophy, neuromuscular disease
- Incomplete or deficient soft tissue surrounding the knee.
- Biomet® Microplasty™ Tibial Trays are contraindicated for use with constrained bearings.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Signature Custom Cutting Guides
Patients receiving a Vanguard Total Knee implanted utilizing non implantable Signature Cutting Guides Surgical Technique.
|
Patients indicated for a total knee replacement utilizing the Vanguard Total Knee System.
|
|
Other: CAS (Computer Assisted Surgery)
Patients receiving a Vanguard Total Knee implanted utilizing non implantable Computer Assisted Surgery Technique.
|
Patients indicated for a total knee replacement utilizing the Vanguard Total Knee System.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mechanical Alignment
Time Frame: Data Collected at 0-10 Weeks; but Analyzed at Completion of Study
|
Angle between femoral head, center of knee, and talus.
|
Data Collected at 0-10 Weeks; but Analyzed at Completion of Study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee Society Objective Score
Time Frame: Completion of Study
|
Objective Scoring of Knee Society score is the clinical assessment which includes the sum of range of motion, stability, flexion contracture, extension lag, and alignment scores.
|
Completion of Study
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Russell A Schenck, PhD, Zimmer Biomet
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 121509
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Joint Disease
-
DePuy OrthopaedicsCompletedNon-inflammatory Degenerative Joint DiseaseUnited States
-
DePuy OrthopaedicsCompletedNon-inflammatory Degenerative Joint DiseaseUnited States
-
Anderson Orthopaedic Research InstituteDePuy Orthopaedics; University of Western Ontario, CanadaCompletedNon-inflammatory Degenerative Joint DiseaseUnited States, Canada
-
DePuy InternationalActive, not recruitingNoninflammatory Degenerative Joint DiseaseUnited States, Hong Kong, Malaysia, Australia, Austria, Belgium, Canada, Germany, New Zealand, Singapore, United Kingdom, South Korea
-
University of AlbertaUniversity of AlbertaCompletedTemporomandibular Degenerative Joint DiseaseCanada
-
Smith & Nephew, Inc.Active, not recruitingDegenerative Joint DiseaseGermany, Spain, Austria
-
DePuy OrthopaedicsCompletedNon-inflammatory Degenerative Joint DiseaseNetherlands
-
Smith & Nephew Pte LtdActive, not recruitingNon-inflammatory Degenerative Joint DiseaseIndia, South Africa, South Korea, Italy
-
Stryker South PacificTerminatedNon-inflammatory Degenerative Joint DiseaseAustralia
-
Biomimedica, IncTerminatedDegenerative Joint Disease of the HipNetherlands
Clinical Trials on Total Knee Replacement with Vanguard Total Knee
-
Hvidovre University HospitalWithdrawnOsteoarthritisDenmark
-
Zimmer BiometCompletedRheumatoid Arthritis | Knee Pain | Chronic Osteoarthritis | Avascular Necrosis of the Femoral Condyle | Moderate Varus, Valgus or Flexion DeformitiesUnited States
-
Zimmer BiometCompletedRheumatoid Arthritis | Knee Pain | Chronic Osteoarthritis | Avascular Necrosis of the Femoral Condyle | Moderate Varus, Valgus or Flexion DeformitiesBelgium, Switzerland, Germany, Israel, Italy
-
Bercovy, Michel, M.D.Completed
-
Mayo ClinicCompleted
-
Zimmer BiometCompletedOsteoarthritis | Traumatic Arthritis | Polyarthritis | RheumatoId ArthritisUnited States
-
Maxx Orthopedics IncCompletedKnee Joint PainUnited States
-
Philip Winnock de Grave, MDAZ DeltaActive, not recruitingOsteoarthritis, KneeBelgium
-
Second Affiliated Hospital, School of Medicine,...Not yet recruiting